BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 10643211)

  • 21. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
    Scheen AJ; Lefèbvre PJ
    Diabetes Care; 1999 Sep; 22(9):1568-77. PubMed ID: 10480527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral agents in the management of type 2 diabetes mellitus.
    Luna B; Feinglos MN
    Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Repaglinide in combination therapy in type 2 diabetes].
    Moses R
    Diabetes Metab; 1999 Dec; 25 Suppl 7():26-7. PubMed ID: 10746009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.
    Rosak C
    J Diabetes Complications; 2002; 16(1):123-32. PubMed ID: 11872380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of type 2 diabetes mellitus. Role of thiazolidinediones.
    Noble J; Baerlocher MO; Silverberg J
    Can Fam Physician; 2005 May; 51(5):683-7. PubMed ID: 15934272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing the progressive nature of type 2 diabetes.
    Cardiovasc J S Afr; 2002; 13(4):211-3. PubMed ID: 12402899
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of type 2 diabetes mellitus: pharmacologic intervention.
    McCormick M; Quinn L
    J Cardiovasc Nurs; 2002 Jan; 16(2):55-67. PubMed ID: 11800068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes management: a comprehensive clinical review of oral medications.
    Quillen DM; Kuritzky L
    Compr Ther; 2002; 28(1):50-61. PubMed ID: 11894443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
    Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI
    N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination oral agent and insulin therapy for type 2 diabetes mellitus.
    Passaro MD; Ratner RE
    Curr Diab Rep; 2001 Oct; 1(2):106-11. PubMed ID: 12643105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
    Bailey T
    Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.
    Mudaliar S; Henry RR
    Annu Rev Med; 2001; 52():239-57. PubMed ID: 11160777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New agents for Type 2 diabetes.
    Nattrass M; Bailey CJ
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Jul; 13(2):309-29. PubMed ID: 10761869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the pharmacologic management of diabetes mellitus.
    Carlton FB
    Emerg Med Clin North Am; 2000 Nov; 18(4):745-53. PubMed ID: 11130936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Where thiazolidinediones will fit.
    Reasner CA
    Diabetes Metab Res Rev; 2002; 18 Suppl 2():S30-5. PubMed ID: 11921436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of thiazolidinediones and sulfonylureas in patients with diabetes.
    Derosa G; Maffioli P
    Diabetes Technol Ther; 2010 Jun; 12(6):491-501. PubMed ID: 20470234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.